Commerzbank: A Neutral Stance, a 4.38% Stake, and a Brussels Ruling Still Outstanding
Published on 10/18/2026 at 19:21 | Editorial boerse-global.de
Commerzbank shares are being pulled in two directions at once, and the latest round of analyst notes does nothing to settle the argument. On one side sits UniCredit's drive for control; on the other, a business that has yet to report its third-quarter 2026 figures. JPMorgan's decision on Friday to keep its "Neutral" rating and 39-euro price target intact is best read as a verdict on neither — it simply signals the US bank saw no reason to move before the numbers land on 5 November.
That distinction matters. An unchanged rating is not a downgrade, nor is it an endorsement of the planned stake-building. RBC Capital Markets had taken a slightly different tack on Tuesday, lifting its target from 40 to 41 euros while holding its "Sector Perform" rating. A higher target, in other words, did not come with a more aggressive recommendation. Deutsche Bank Research, for its part, left its "Hold" rating and 42-euro target untouched on Thursday.
Two Clocks, Two Different Questions
The ownership story and the earnings story run on separate timetables, and conflating them is where investors tend to go wrong. On the ownership side, the ECB gave UniCredit permission on Thursday to push its stake in Commerzbank past 30% and build without an upper limit. That is a green light, not a completed takeover. UniCredit expects to clear the remaining procedures and conditions by year-end, after which it is targeting roughly 50% of voting rights — enough to take control.
What still stands in the way is a decision from the EU Commission as competition authority, expected by 16 November. Until that lands, the gap between permission granted and control achieved remains wide open.
Should investors sell immediately? Or is it worth buying Commerzbank?
What the Filings Actually Say
BlackRock disclosed on Thursday a combined position of 4.38% of voting rights and instruments in Commerzbank, with 9 October named as the threshold date. The figure bundles instruments alongside shares, so it cannot be read as a pure equity stake — and it certainly does not prove the asset manager added to its holdings. The composition of such filings carries more weight than any headline reading of them as a buy signal.
Commerzbank itself, meanwhile, has been buying. The bank repurchased 2,987,942 of its own shares between 5 and 9 October under its running buyback programme, a detail it published on 12 October. Those transactions are done and dusted — a world away from UniCredit's forward-looking expectations about where its stake might end up. Neither disclosure, though, tells you anything about how the remaining approvals will play out.
The Date That Anchors Everything
Come 5 November, Commerzbank reports its third-quarter 2026 results, the next scheduled checkpoint for judging how the operating business is actually performing. The analyst calls should be read in that light: they are pre-earnings assessments, not verdicts on results already in the books.
Commerzbank at a turning point? This analysis reveals what investors need to know now.
JPMorgan's unchanged stance does not resolve the tension between takeover hopes and standalone valuation. If anything, it offers a sober counterweight: the prospect of a dominant shareholder does not automatically translate into a higher rating. What counts is how the business develops — and how the outstanding regulatory processes unfold. Progress on one front is no substitute for hard evidence on the other.
Ad
Commerzbank Stock: New Analysis - 18 October
Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
